EUVIMEDEUVIMED entdecken
Crossref

Self-Reported Compliance With Adjuvant Endocrine Therapy in Young Women With Hormone Receptor-Positive Early Breast Cancer: A Real-World Study from a Tertiary Cancer Center in India

Mehak Trikha, Sushmita Rath, Pradeep Ventrapati, Prabhat Bhargava, Altaf Siddiqui, Akash Pawar, Priyanka Patil, Revathy Krishnamurthy, Ayushi Sahay, Palak Popat, Purvi Haria, Sneha Shah und 9 weitere

Clinical Breast Cancer · 2026

DOI: 10.1016/j.clbc.2026.08.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2026. Verfasst von Mehak Trikha und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute HBNI, Mumbai, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Hormonal, Self Report, Drug Monitoring. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAntineoplastic Agents, HormonalSelf ReportDrug MonitoringMedication AdherenceHumansFemaleIndiaRetrospective StudiesAdultChemotherapy, AdjuvantYoung AdultAdolescentTertiary Care CentersReceptors, EstrogenReceptors, ProgesteroneFollow-Up StudiesAdherence Interventions

Stichwörter der Autor:innen

AdherenceHormone therapyLow and Middle Income CountrySurvivalYoung breast cancer (YBC)

Substanzen

Antineoplastic Agents, HormonalReceptors, EstrogenReceptors, Progesterone

Autor:innen und Institutionen

  • Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute HBNI, Mumbai, India.
  • Department of Medical Oncology, Apollo Hospital, Mumbai, India.
  • Department of Biostatistics, Tata Memorial Centre, Homi Bhabha National Institute HBNI, Mumbai, India.
  • Clinical Operations, Reg & Start Up, IQVIA, Mumbai, India.
  • Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute HBNI, Mumbai, India.
  • Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute HBNI, Mumbai, India.

Zitieren

APA

Trikha, M., Rath, S., Ventrapati, P., Bhargava, P., Siddiqui, A., Pawar, A., Patil, P., Krishnamurthy, R., Sahay, A., Popat, P., Haria, P., Shah, S., Kapu, V., Sekar, A., Pathak, R., Joshi, S., Wadasadawala, T., Sarin, R., Badwe, R., …, & Bajpai, J. (2026). Self-Reported Compliance With Adjuvant Endocrine Therapy in Young Women With Hormone Receptor-Positive Early Breast Cancer: A Real-World Study from a Tertiary Cancer Center in India. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2026.08.003

Vancouver

Trikha M, Rath S, Ventrapati P, Bhargava P, Siddiqui A, Pawar A, et al. Self-Reported Compliance With Adjuvant Endocrine Therapy in Young Women With Hormone Receptor-Positive Early Breast Cancer: A Real-World Study from a Tertiary Cancer Center in India. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2026.08.003

BibTeX
@article{Trikha2026,
  author = {Trikha, Mehak and Rath, Sushmita and Ventrapati, Pradeep and Bhargava, Prabhat and Siddiqui, Altaf and Pawar, Akash and Patil, Priyanka and Krishnamurthy, Revathy and Sahay, Ayushi and Popat, Palak and Haria, Purvi and Shah, Sneha and Kapu, Venkatesh and Sekar, Anbarasan and Pathak, Rima and Joshi, Shalaka and Wadasadawala, Tabassum and Sarin, Rajiv and Badwe, Rajendra and Gupta, Sudeep and Bajpai, Jyoti},
  title = {Self-Reported Compliance With Adjuvant Endocrine Therapy in Young Women With Hormone Receptor-Positive Early Breast Cancer: A Real-World Study from a Tertiary Cancer Center in India},
  journal = {Clinical Breast Cancer},
  year = {2026},
  doi = {10.1016/j.clbc.2026.08.003}
}
Kostenlos starten →